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INTRODUCTION
Hyperkalemia can have multimodal effect on myo-
cardial protection during ischemia/reperfusion. Ex-
tracellular myocardial K+ concentration ([K+]o) in
ischemic regions increase to 10-20 mM after 3-10
min of ischemia (1, 2). Hyperkalemia may preserve
adenosine triphosphate (ATP) by reducing excitabil-
ity of cardiac cells in energy-limited state. Hyperka-
lemic cardiac arrest is used as a protective interven-
tion during cardiac surgery (3). In addition, Na+/
K+-ATPase activation induced by hyperkalemia may
exert a cardioprotective effect (4). However, mem-
brane depolarization induced by hyperkalemia may
cause detrimental effects in myocardial cells by
inducing activation of a reversal mode of the Na+/
Ca2+ exchanger and/or slow Ca2+ channels (5).
Conversely, decreased myocardial Na+/K+-ATPase
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activity is associated with decreased post-ischemic
recovery (6, 7). The Na+/K+-ATPase activity is inhib-
ited by various factors including the therapeutic use
of cardiotonic steroids such as digoxin (8, 9), en-
dogenous cardiotonic steroids (10-12), hypothermia
(4), and ischemia (13, 14). Cardiotonic steroids may
abolish the protective effects of hyperkalemia. In
contrast, [K+]o elevation decreases the affinity of
Na+/K+-ATPase for cardiotonic steroids (15-17).
Hyperkalemia may counteract the inhibition of Na+/
K+-ATPase induced by cardiotonic steroids during
ischemia. However, the effect has not yet been in-
vestigated in ischemia/reperfusion studies.
We hypothesized that hyperkalemia during ische-
mia has a cardioprotective effect during ischemia/
reperfusion and that the effects are partly mediated
by the preservation of Na+/K+-ATPase activity. To
test this hypothesis, we investigated whether hy-
perkalemia and ouabain, a synthetic cardiotonic ster-
oid, modulate the loss of membrane integrity and
bleb formation during simulated ischemia/reperfu-
sion in cultured neonatal rat cardiomyocytes. The
suggested results were confirmed in a second set
of experiments measuring diastolic [Ca2+]i and myo-
cardial excitability during ischemia
MATERIALS AND METHODS
All experimental procedures and protocols used
in this study were reviewed and approved by the
Animal Investigation Committee of Tokushima Uni-
versity and followed the guidelines of the American
Physiological Society (Bethesda, Maryland) for the
use of animals in research.
Cell culture
Primary cultures of neonatal rats were prepared
from the hearts of 2-day-old Sprague-Dawley rats
with a Neonatal Cardiomyocyte Isolation System
(Worthington Biochemical Corp., Lakewood, NJ).
This system, which utilizes purified enzyme prepa-
rations, provides a reliable and consistent cell iso-
lation method (18). Neonatal rats were anesthetized
with sevoflurane and their hearts were quickly re-
moved. Isolation was performed according to the
manufacturer’s recommendations (18). The cells
were maintained in M199 culture medium supple-
mented with 10% fetal bovine serum, gentamycin
(50 μgml-1), and amphotericin B (2.5 μgml-1) in
35-mm glass-bottomed culture dishes (MacTek
Corp, Gates Mills, OH). Experiments were initiated
after 4 days of incubation for calcein studies and 3
days of incubation for fluo-4 studies at 37in a 5%
CO2 environment using monolayers of spontane-
ously beating myocytes.
Measurement of loss of membrane integrity and bleb
formation during simulated ischemia/reperfusion
Simulated ischemia using NaCN, an inhibitor of
mitochondrial cytochrome oxidase, and 2-deoxyglu-
cose, an inhibitor of glycolysis, has been used in
ischemia/reperfusion or ischemia studies (5, 19).
The vital dye calcein-AM was used to assess mem-
brane integrity (20-22). Necrotic blebs form in cells
exposed to intense noxious stimuli such as hypoxia/
reoxygenation and appear prior to cell permeabili-
zation (20, 23). We selected an ouabain concentra-
tion (100 μM) that resulted in 50% inhibition of Na+/
K+-ATPase but produces no loss of viability in neo-
natal rat cardiomyocytes (24).
Loading with the vital dye calcein AM (Molecular
Probes, Eugene, OR) was accomplished by incuba-
tion with calcein AM (200 nM in phosphate- buff-
ered saline) for 20 min. The cells were maintained
at 37for another 20 min to ensure complete hy-
drolysis after washing with phosphate-buffered
saline.
A cell perfusion system was designed to meas-
ure cell fluorescence in response to rapid solution
changes. The system used an inverted epifluores-
cence microscope (Eclipse TS100, Nikon, Tokyo,
Japan). A culture dish incubation system (Harvard
Apparatus, DH-35i, Holliston, MA) was placed on
the microscope stage. In addition, 35-mm glass-
bottomed culture dishes and a chamber insert
closed for 35-mm dishes (Harvard Apparatus, RC-
37FC) were mounted on the incubation system.
Cell perfusion solutions were infused using an in-
fusion pump at a rate of 2 mlmin-1. Solutions were
maintained at a constant temperature by a 35-mm
tissue culture dish heater (Harvard Apparatus, DH-
35), solution in-line heater (Harvard Apparatus,
SH-27B), and chamber system heater controller
(Harvard Apparatus, TC-344B).
Excitation of calcein was obtained using a Xenon
lamp (50 W ; Nikon) filtered at 450-490 nm and re-
flected to the microscope objective (20, CFI Plan
Fluor ELWD 20C ; Nikon, Tokyo, Japan) by a di-
chroic mirror centered at 505 nm. Cell fluorescence
was collected by the objective, passed through a 520-
nm-long path filter, and directed to a cooled digital
B/W CCD camera (ORCA, Hamamatsu Photonics,
Hamamatsu, Japan).
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Relative changes in the calcein fluorescence in-
tensity in each region of interest (ROI) relative to
the baseline (%) were used as an index of mem-
brane integrity. The times until bleb appearance in
the ROIs were also recorded. The ROI included al-
most all cells in a single field of view of the micro-
scope, which included more than fifty cells. Fluo-
rescence images with an exposure time of 555 msec
were taken every 30 seconds using a computer-con-
trolled shutter. The cells were initially perfused with
“normal” perfusate i.e., Earle’s balanced salt solution
(EBSS), containing (in mM) 116.4 NaCl, 5.4 KCl,
1.8 CaCl2, 0.8 MgSO4, 26.2 NaHCO3, 1 NaH2PO4,
and 5.6 D-glucose, which was titrated to pH 7.40.
After equilibration (approximately 10 min), the per-
fusate was randomly switched to one of treatment
solutions : EBSS (CON ; n=6), EBSS containing 100
μM ouabain (OUA ; n=5), modified EBSS contain-
ing NaCN and 2-deoxyglucose (ISC ; n=6), ISC+
HIK (n=6), ISC+OUA (n=6) or ISC+HIK+OUA
(n=6), and measurements were performed for 15
min. The perfusate was then switched back to nor-
mal perfusate to measure reperfusion injury for an
additional 30 min at 37.
Measurement of myocardial excitability and diastolic
[Ca2+]i during ischemia
Cultured neonatal rat cardiomyocytes have been
used to study spontaneous beating (18, 25). A pha-
sic rise and fall in fluorescence is well-established
as representing the systolic rise and diastolic fall
of [Ca2+]i upon which contraction and relaxation de-
pend (25, 26). Therefore, we used the rhythmical
fluorescence changes as an index of myocardial ex-
citability in the fluorescence images. Loading with
the Ca2+ indicator, fluo-4 AM (Molecular Probes,
Eugene, OR), was accomplished by incubation with
fluo-4 AM (5 μM in phosphate-buffered saline) for
20 min at room temperature ; the cells were main-
tained at 37for another 20 min to ensure com-
plete hydrolysis after washing with phosphate-buff-
ered saline. We used the same cell perfusion and
epifluorescence system as the calcein study. Fluo-
rescence images with an exposure time of 334 msec
were taken for 15 sec at 2 framess-1 at 5 minute
intervals using a computer-controlled shutter and
an image processing system.
The cells were initially superfused with control
perfusate. After equilibration (approximately 10
min), the perfusate was randomly switched to one
of treatment solutions : CON (n=5), HIK (n=5),
OUA (n=5), ISC (n=5), ISC+HIK (n=5), ISC+OUA
(n=5) or I SC+HIK+OUA (n=5). Measurements
were taken for 45 min at 37.
Data analysis was performed as follows. We chose
3-7 ROIs, which contained a cell or small clusters
of cells and met the criteria for selection, at ran-
dom from a single field of view of the microscope.
The criteria for selection were that the fluorescences
of ROI changed rhythmically and that the diastolic
fluorescence did not increase until the intervention.
Representative traces of fluo-4 fluorescence value
are presented in Figure 1. Background values (mini-
mum value in the windows of the ROIs that in-
cluded the area outside of the cells) were always
subtracted. Diastolic fluo-4 fluorescence values in
Figure 1. Graph showing representative traces of fluo-4 fluorescence in the CON, HIK, ISC, and ISC+HIK groups. After equili-
bration with “normal” perfusate (Earle’s balanced salt solution EBSS) for approximately 10 min, the perfusate was switched to either
EBSS (CON), modified EBSS containing 16 mM KCl (HIK), modified EBSS containing 5 mM NaCN and 5.5 mM 2-deoxyglucose
(ISC), or modified EBSS containing 5 mM NaCN, 5.5 mM 2-deoxyglucose, and 16 mM KCl (ISC+HIK).
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the ROIs were evaluated by calculating the mean
value of the bottom five average pixel intensities in
the 30 fluorescence images. Fluo-4 fluorescence
was expressed relative to the baseline value (%). If
at least one rhythmical increase in fluorescence was
observed over 15 seconds, we considered the cell
or cell mass to have retained excitability. Changes
in excitability of cardiomyocytes were expressed as
percentages of excitable myocardial cells (Figure 2).
Statistical analysis
Data are expressed as the meanSD. Compari-
son of several means of diastolic intracellular [Ca2+]i,
calcein fluorescence intensities, and the times un-
til bleb appearance were performed using a two-
way analysis of variance followed by a Student-
Newman -Keuls post -hoc test for multiple com-
parisons. All P-values are two-tailed. Comparisons
of myocardial excitability were performed using
Fisher’s exact test. A P-value of less than 0.05 was
considered significant. Statistical analysis of the data
was performed using the commercially available
software program StatView 5.0 (SAS Institute Inc.,
Cary, NC).
RESULTS
Effects of hyperkalemia in the presence or absence of
ouabain on membrane integrity and bleb formation
during simulated ischemia/reperfusion
Three patterns were observed in the loss of cal-
cein fluorescence : gradual loss, abrupt loss with
bleb formation, and abrupt loss without bleb forma-
tion (Figure 3). The latter two patterns were ob-
served to have similar timings in this study to those
reported in another study (22). The times until
bleb appearance in the CON, OUA ISC, ISC+HIK,
ISC+OUA ISC+OUA+HIK group were 3512 min,
2914 min, 2013 min, 2711 min, 134 min*,
and 2412 min, respectively (*P0.05 vs. CON).
During control perfusion at 37, gradual decreases
in calcein fluorescence were observed (Figure 4, 5).
However, appearance of bleb delayed until 35 min.
Thus, although some cells in the CON group suf-
fered a loss of membrane integrity, the majority of
the decrease in calcein fluorescence was likely in-
duced by dye leakage or photobleaching. Ouabain
itself did not produce a significant difference from
control. Abrupt losses of calcein fluorescence were
Figure 2. Time course of myocardial excitability in neonatal rat cardiomyocytes during treatment : control (CON), 16 mM KCl
(HIK), 100 μM ouabain (OUA), simulated ischemia (ISC), simulated ischemia plus 16 mM KCl (ISC+HIK), simulated ischemia plus
100 μM ouabain (ISC+OUA), and simulated ischemia plus 16 mM KCl plus 100 μM ouabain (ISC+HIK+OUA). Simulated ischemia
was induced by 5 mM NaCN and 5.5 mM 2-deoxyglucose. If at least one rhythmical increase in fluorescence was observed over 15
seconds, we considered the cell or the cell mass to have retained excitability. Myocardial excitability was expressed as the percent-
age of excitable cells in each group at every measured point (%). *P0.05 vs. CON. #P0.05 vs. ISC.
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Figure 3. Figure showing representative changes in calcein fluorescence in the CON and ISC+OUA group. After equilibration
with “normal” perfusate (Earle’s balanced salt solution EBSS) for approximately 10 min, the perfusate was switched to either EBSS
(CON) or modified EBSS containing 5 mM NaCN, 5.5 mM 2-deoxyglucose, and 100 μM ouabain (ISC+OUA). Figures were ob-
tained at baseline, 15, 30, and 45 min. Arrows indicate blebs.
Figure 4. Time course of calcein fluorescence during and after treatment in time control (CON), 100 μM ouabain (OUA), simu-
lated ischemia (ISC), simulated ischemia plus 16 mM KCl (ISC+HIK), simulated ischemia plus 100 μM ouabain (ISC+OUA), or
simulated ischemia plus 16 mM KCl plus 100 μM ouabain (ISC+HIK+OUA) groups. Simulated ischemia was induced by 5 mM NaCN
and 5.5 mM 2-deoxyglucose. Calcein fluorescence was measured relative to baseline (%). Data are represented as the meanSD.
Figure 5. Effects of treatment/reperfusion on calcein fluorescence in cultured neonatal rat cardiomyocytes : control (CON), 100
μM ouabain (OUA), simulated ischemia (ISC), simulated ischemia plus 16 mM KCl (ISC+HIK), simulated ischemia plus 100 μM
ouabain (ISC+OUA), and simulated ischemia plus 16 mM KCl plus 100 μM ouabain (ISC+HIK+OUA). Simulated ischemia was in-
duced by 5 mM NaCN and 5.5 mM 2-deoxyglucose. Evaluation was performed at reperfusion, 15 min after reperfusion, and 30 min
after reperfusion. Values are expressed as the meanSD. *P0.05 vs. CON. #P0.05 vs. ISC+OUA.
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observed after reperfusion in many cells in the ISC
group (Figure 4). The timing of appearance of the
bleb is consistent with the abrupt loss of calcein
fluorescence, suggesting reperfusion injury.
Perfusion with ouabain during simulated ische-
mia induced bleb formation in few cells (Figure 3,
4). Abrupt losses of calcein fluorescence were ob-
served in most cells after reperfusion (Figure 4),
although significant differences were not observed
between the ISC and ISC+OUA groups. Difference
with the CON group became significant in the times
until bleb appearance. Thus, ouabain may acceler-
ate and potentiate the membrane injury induced by
simulated ischemia/reperfusion. Perfusion with hy-
perkalemia during simulated ischemia/reperfusion
did not induce any difference in calcein fluorescence
relative to the CON group, suggesting protective
effects (Figure 5).
Hyperkalemia during simulated ischemia/reperfu-
sion inhibits the decrease in calcein fluorescence in-
duced by ischemia/reperfusion even in the presence
of ouabain (Figure 4). Significant differences were
observed in the calcein fluorescence between the
ISC+OUA and the ISC+OUA+HIK group (Figure
5). Thus, the preventive effect became obvious in
the presence of ouabain. Hyperkalemia nearly com-
pletely inhibited the effects of ouabain during ische-
mia/reperfusion.
Effects of hyperkalemia on myocardial excitability
and diastolic [Ca2+]i during simulated ischemia in
the presence or absence of ouabain
The change in myocardial excitability and diastolic
[Ca2+]i in the ouabain group occurred over a simi-
lar time course as that of the control (Figure 6).
Hyperkalemia induced diastolic arrest within ap-
proximately 5 min (Figure 6). Simulated ischemia
in the absence and presence of ouabain also in-
duced diastolic arrest within approximately 10 min
and 8 min, respectively (Figure 6). Significant dif-
ferences were observed between hyperkalemia
groups and ischemia group at 5 min.
Hyperkalemia and ouabain did not significantly
increase diastolic [Ca2+]i in the absence of ischemia
(Figure 6, 7). Simulated ischemia with and without
hyperkalemia induced significant increases in dia-
stolic [Ca2+]i after 25 min and 15 min, respectively.
Significant differences between the ISC+HIK and
Figure 6. Time course of diastolic fluo-4 fluorescence in neonatal rat cardiomyocytes during treatment : control (CON), 16 mM
KCl (HIK), 100 μM ouabain (OUA), simulated ischemia (ISC), simulated ischemia plus 16 mM KCl (ISC+HIK), simulated ischemia
plus 100 μM ouabain (ISC+OUA), and simulated ischemia plus 16 mM KCl plus 100 μM ouabain (ISC+HIK+OUA). Simulated ische-
mia was induced by 5 mM NaCN and 5.5 mM 2-deoxyglucose. Fluo-4 fluorescence was measured relative to baseline (%). Data are
presented as the meanSD. *P0.05 vs. CON. #P0.05 vs. ISC. $P0.05 vs. ISC+OUA
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ISC group and between the ISC+HIK and HIK
group were observed after 20 min and 30 min, re-
spectively. Thus, hyperkalemia delayed and inhib-
ited the increase in diastolic [Ca2+]i induced by simu-
lated ischemia, suggesting cardioprotective effects,
although hyperkalemia did not fully abolished the
effects of ischemia (Figure 6, 7).
Simulated ischemia with ouabain induced signifi-
cant increases in diastolic [Ca2+]i after 10 min. Sig-
nificant differences between the ISC+OUA and ISC
group were observed between 25 min and 40 min.
Thus, ouabain accelerated and potentiated the in-
crease in diastolic [Ca2+]i induced by simulated
ischemia (Figure 6, 7).
Simulated ischemia under hyperkalemia condi-
tions with and without ouabain induced significant
increases in diastolic [Ca2+]i after 35 min and 25 min,
respectively. Thus, hyperkalemia almost completely
inhibited the effects of ouabain during simulated
ischemia (Figure 6, 7).
DISCUSSION
Cardiotonic steroids and effects of hyperkalemia on
myocardial protection during ischemia/reperfusion
Our results suggest that hyperkalemia during
ischemia is cardioprotective against ischemia/reper-
fusion insult. One of possible mechanisms is the
antagonistic effect of hyperkalemia on cardiotonic
steroids. Ouabain itself did not alter membrane in-
tegrity, bleb formation, myocardial excitability, or
diastolic [Ca2+]i in this study. Although nontoxic con-
centrations of ouabain (up to 100 μM) cause a less
than twofold increase in diastolic [Ca2+]i (27), it does
not cause arrhythmic contraction and have no ef-
fect on cell viability in neonatal rat cardiomyocytes
(24, 27). Our results suggest that ouabain acceler-
ated and potentiated the increase in diastolic [Ca2+]i
during ischemia and possibly the membrane injury
during ischemia/reperfusion. These data suggest
that myocardial tolerance to ischemia is reduced
during partial inhibition of Na+/K+-ATPase.
Hyperkalemia almost completely inhibited the ef-
fects of ouabain during ischemia/reperfusion in this
study. These results confirmed by the increase in
diastolic [Ca2+]i during ischemia. Extracellular K+
is known to counteract the inhibition of Na+/K+-
ATPase by cardiotonic steroids (16, 17), including
a neonatal rat study (15). Hermans et al. reported
a possible mechanism of the antagonism (16). K+
and ouabain bind to different conformational states
of the Na+/K+-ATPase (E2-P and E2-P Na2, respec-
tively), which are transiently exposed to the exter-
nal side of the sarcolemma. Upon K+ binding the
state (E2-P K2) is removed from the extracellular
side. If the K+ concentration is increased, more E2-
P K2 is formed and, consequently, active Na+-K+
transport is enhanced. At the same time, less E2-P
Na2 is available for ouabain binding (16). Many stud-
ies have demonstrated that serum (11) and myo-
cardial (12, 28) cardiotonic steroid activity levels
are significantly increased during acute myocardial
ischemia and that anti-digoxin antiserum has a
Figure 7. Effects of treatment on diastolic fluo-4 fluorescence in cultured neonatal rat cardiomyocytes : control (CON), 16 mM
KCl (HIK), 100 μM ouabain (OUA), simulated ischemia (ISC), simulated ischemia plus 16 mM KCl (ISC+HIK), simulated ischemia
plus 100 μM ouabain (ISC+OUA), and simulated ischemia plus 16 mM KCl plus 100 μM ouabain (ISC+HIK+OUA). Simulated ische-
mia was induced by 5 mM NaCN and 5.5 mM 2-deoxyglucose. Evaluation was performed at 20 min and 35 min. Values are expressed
as meanSD. *P0.05 vs. CON. #P0.05 vs. ISC. $P0.05 vs. ISC+OUA
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protective effect against myocardial ischemia-reper-
fusion injury (11, 12). We did not provide direct evi-
dence that simulated ischemia induces the release
of cardiotonic steroids or hyperkalemia enhance
myocardial membrane Na+/K+-ATPase activity in
the present study. In addition, released cardiotonic
steroids could have been washout because myocar-
dial cells were continuously superfused in this study.
Therefore, whether this mechanism was responsi-
ble for the results of the ISC group is not clear.
However, it is clear that hyperkalemia strongly in-
hibited the effects of ouabain during ischemia. Myo-
cardial cells may be exposed to the condition such
as that of the ISC+HIK+OUA group at the site of
myocardial ischemia. Therefore, we suppose that
the cardioprotective effects of hyperkalemia may
be induced by the inhibition of cardiotonic steroids.
The effects of activation of Na+/K +-ATPase induced
by hyperkalemia on myocardial protection during
ischemia/reperfusion
Activation of Na+/K+-ATPase is another possible
mechanism of hyperkalemia-induced myocardial
protection (4). Although Na+/K+-ATPase is activated
to a considerable extent under normal [K+]o condi-
tions (29), Terkildsen et al. suggested that Na+/K+
pump amplitude declines rapidly during phase one
of simulated ischemia to a level 65% of normoxic
pump current and the increases in [K+]o are sug-
gested to stimulate pump activity during phase one
and phase two (the plateau phase) (30). Ouabain
did not abolish the protective effects of hyperkalemia
in this study. Indeed, dihydro-ouabain did not affect
the activation of Na+/K+ pump current on [K+]o in
cardiac ventricular myocytes, although Na+/K+ pump
current decreased in the presence of dihydro-
ouabain (16). Yamamoto et al. reported that meta-
bolic inhibition abolished the hyperkalemia-induced
cardioprotective effects induced by Na+/K+-ATPase
activation during normothermic reperfusion (4).
Therefore, activation of Na+/K+-ATPase may not be
the main mechanism of the cardioprotective effects
of hyperkalemia during ischemia, although we can-
not deny the mechanism.
Membrane potential and the effects of hyperkalemia
on myocardial protection during ischemia/reper-
fusion
Diastolic arrest may have beneficial effects in
myocardial cells under an energy-limited condition
and could be another possible mechanism. A pre-
vious report suggested that 15 mM hyperkalemic
solutions induce a depolarization of the resting mem-
brane potential (Vm) to -66 mV from a resting Vm
of -87 mV in adult rat cardiomyocytes (5). At this
depolarized potential, the fast Na+ channels are in-
activated because the threshold is -70 to -65 mV,
resulting in diastolic arrest (3). Thus, high [K+]o
may preserve ATP by reducing excitability of car-
diac cells. However, ischemia also reduces the ex-
citability of cardiac cells, although differences of sev-
eral minutes were observed. The impact of the en-
ergy saving effects on the results is unclear. Baczko
et al. reported that increased [K+]o during ischemia
and reperfusion can lead to increased Ca2+ overload
and cell hypercontracture/death, which increases
in parallel with depolarization (5). However, in their
study, hyperkalemic conditions were maintained at
the time of reperfusion, in contrast with our study.
Reversal of increased [K+]o after reperfusion could
decrease membrane potential, which was suggested
in our preliminary study using a voltage-sensitive
dye bis - (1,3 -dibutylbarbituric acid) trimethine
oxonol bis-oxonol (31) (Data not shown).
Experimental model and limitations of this study
Modeling ischemia/reperfusion is difficult be-
cause of complicated and interdependent processes
(32). We determined minimum exposure time for
the induction of reperfusion injury using bis-oxonol
in a preliminary study (data not shown). And, reper-
fusion-induced membrane injury and reperfusion-
induced membrane depolarization observed in this
study and in preliminary studies using bis-oxonol
(data not shown) suggest successful simulation of
reperfusion injury. Although relatively large dish-
to-dish or cell-to-cell variation was observed, het-
erogeneity of the myocardial cell response to ische-
mia is well documented (32-34). To simplify the
model, we investigated ischemia only and selected
relatively intact cells in the second series of study.
Ca2+ overload increased prior to reperfusion and the
determinants of Na+ overload are important deter-
minants of Ca2+ overload in reperfused myocytes
(14). Calpain activation, which occurs when reper-
fusion is induced by elevated diastolic [Ca2+]i, in-
duces inactivation of Na+/K+-ATPase and further
calpain activation, resulting in sarcolemmal rup-
ture and cell death (14). In fact, we observed that
hyperkalemia applied only during the ischemic pe-
riod affected membrane injury and bleb formation
after reperfusion.
In our study, we used cultured neonatal rat cardio-
myocytes as a model. Several studies have suggested
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that immature myocytes have poorly developed
sarcoplasmic reticulum and lack fully developed
Ca2+ channels (35). There is a slight developmental
change in a2 and a3 isoforms 14-21 days after birth
(36). However, neonatal and adult cells have com-
parable time courses of the rise in [Ca2+]i, develop-
ment of sarcolemmal blebs and cumulative enzyme
release during energy depletion. (19). Although we
must explore this result to adult heart carefully,
myocardial protection of juvenile heart is itself clini-
cally important (37). Eliminations of spontaneous
activity were observed in some cells during fluo-4
loading and control perfusion in this study, suggest-
ing damage caused by these procedures (38).
Although hyperkalemic cardioplegic solutions
have a number of problems in cardiac surgery (3),
hyperkalemia may counteract the effects of car-
diotonic steroids if applied under normothermia.
In conclusion, the data obtained in the present
study suggest three important findings. First, 15
mM hyperkalemia during ischemia may be cardio-
protective against ischemia/reperfusion insult in
neonatal cardiomyocytes if applied to intact cells un-
der normothermia. Second, inhibition of Na+/K+-
ATPase activity during ischemia accelerates and
potentiates myocardial injury induced by ischemia/
reperfusion. Third, hyperkalemia during ischemia
almost completely inhibits the effects of cardiotonic
steroids during ischemia/reperfusion. We propose
that preservation of Na+/K+-ATPase activity induced
by the antagonistic effect of [K+]o on endogenous
or therapeutic cardiotonic steroids may play a role
in the cardioprotective effects of hyperkalemia.
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